Oral cancer aetiopathogenesis; past, present and future aspects

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 16, Issue 3, 2011, Pages 306-311

  Scully, Crispian ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Alcohol; Betel; Diagnosis; Oral cancer; Prevention; Tobacco

Indexed keywords

ALCOHOL; MOLECULAR MARKER; PROTEIN P53;

ALCOHOL CONSUMPTION; ARTICLE; BACTERIAL INFECTION; BETEL NUT; CANCER DIAGNOSIS; CANCER PREVENTION; CANCER RISK; CANDIDIASIS; CARCINOGENESIS; CHROMOSOME 3P; CHROMOSOME 9P; CIGARETTE SMOKING; DIET SUPPLEMENTATION; DIETARY INTAKE; DNA DAMAGE; EARLY DIAGNOSIS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; GENE MUTATION; GENETIC PREDISPOSITION; HEAD AND NECK CANCER; HERPES VIRUS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; LIFESTYLE MODIFICATION; LYMPH NODE METASTASIS; MEDITERRANEAN DIET; MOUTH CANCER; MOUTH HYGIENE; PATHOGENESIS; PATIENT EDUCATION; RADIATION PROTECTION; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SOCIAL STATUS; TOBACCO; TOBACCO DEPENDENCE; VACCINATION; VIRUS INFECTION; WART VIRUS;

FORECASTING; HUMANS; MOUTH NEOPLASMS; RISK FACTORS;

EID: 79957953897     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.16.e306     Document Type: Article

References (68)

1. Surveillance Epidemiology and End Results (SEER). SEER Cancer Statistics Review 1975-2004. National Cancer Institute. http://seer.cancer.gov/statfacts/html/oralcav. (Accessed 03.07.2010).
2. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for squamous cell carcinoma of the oral cavity in young people--a comprehensive literature review. Oral Oncol. 2001;37:401-18.
3. Møller H. Changing incidence of cancer of the tongue, oral cavity, and pharynx in Denmark. J Oral Pathol Med. 1989;18:224-9.
4. Macfarlane GJ, Boyle P, Scully C. Rising mortality from cancer of the tongue in young Scottish males. Lancet. 1987;2:912.
5. Macfarlane GJ, Boyle P, Evstifeeva TV, Robertson C, Scully C. Rising trends of oral cancer mortality among males worldwide: the return of an old public health problem. Cancer Causes Control. 1994;5:259-65.
6. Shiboski CH, Schmidt BL, Jordan RC. Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer. 2005;103:1843-1849.
7. Herrero R, Castellsagué X, Pawlita M, Lissowska J, Kee F, Balar- am P, et al. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst. 2003;95:1772-83.
8. D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, et al. Case-control study of human papillomavirus and oropha-ryngeal cancer. N Engl J Med. 2007;356:1944-56.
9. Blot WJ, McLaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, et al. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 1988;48:3282-7.
10. International Agency on Research for Cancer. Smokeless Tobacco and Some Tobacco-specifc N-Nitrosamines. Monographs Vol. 89 Lyon: IARC 2007.
11. Karolinska Institute. Health Risks from Swedish Snuff. Ed. Cnat-tingius S, Galanti R, Grafstrom R, Hergens M-P, Nyren O, Pershagen G, Wickholm S. 2005. p. 1-95.
12. Warnakulasuriya S, Sutherland G, Scully C. Tobacco, oral cancer, and treatment of dependence. Oral Oncol. 2005;41:244-60.
13. Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989;17:691-4.
14. Ernst E. Harmless herbs? A review of the recent literature. Am J Med. 1998;104:170-8.
15. Boucher BJ, Mannan N. Metabolic effects of the consumption of Areca catechu. Addict Biol. 2002;7:103-10.
16. Tominaga S. Major avoidable risk factors of cancer. Cancer Lett. 1999;143 Suppl 1:S19-23.
17. Petti S, Scully C. Alcohol and oral health.(2009). In "Food constituents and oral health: current status and future prospects" Ed: Wilson M. Woodhead Publishing Ltd.; Cambridge. p. 350-380.
18. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009;31:1228-39.
19. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009;18:2406-2412.
20. Abnet CC, Kamangar F, Islami F, Nasrollahzadeh D, Brennan P, Aghcheli K, et al. Tooth loss and lack of regular oral hygiene are associated with higher risk of esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2008;17:3062-3068.
21. Meurman JH, Uittamo J. Oral micro-organisms in the etiology of cancer. Acta Odontol Scand. 2008;66:321-326.
22. Homann N, Tillonen J, Meurman JH, Rintamäki H, Lindqvist C, Rautio M, et al. Increased salivary acetaldehyde levels in heavy drinkers and smokers: a microbiological approach to oral cavity can cer. Carcinogenesis. 2000;21:663-668.
23. O'Grady JF, Reade PC. Candida albicans as a promoter of oral mucosal neoplasia. Carcinogenesis. 1992;13:783-786.
24. Tillonen J, Homann N, Rautio M, Jousimies-Somer H, Salaspuro M. Role of yeasts in the salivary acetaldehyde production from etha-nol among risk groups for ethanol-associated oral cavity cancer. Alcohol Clin Exp Res. 1999;23:1409-1415.
25. Nieminen MT, Uittamo J, Salaspuro M, Rautemaa R. Acetalde-hyde production from ethanol and glucose by non-Candida albicans yeasts in vitro. Oral Oncol. 2009;45:e245-e248.
26. Miller CS, Johnstone BM. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;91:622-635.
27. Shillitoe EJ. The role of viruses in squamous cell carcinoma of the oropharyngeal mucosa. Oral Oncol. 2009;45:351-355.
28. Feller L, Wood NH, Khammissa RA, Lemmer J. Human pap-illomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 1: human papilloma-virus-mediated carcinogenesis. Head Face Med. 2010;6:14.
29. Feller L, Wood NH, Khammissa RA, Lemmer J. Human pap-illomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papilloma-virus associated oral and oropharyngeal squamous cell carcinoma. Head Face Med. 2010;6:15.
30. Popović B, Jekić B, Novaković I, Luković L, Konstantinović V, Babić M, et al. Cancer genes alterations and HPV infection in oral squamous cell carcinoma. Int J Oral Maxillofac Surg. 2010;39:909-915.
31. Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tân PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
32. D'Souza G, Zhang HH, D'Souza WD, Meyer RR, Gillison ML. Moderate predictive value of demographic and behavioral characteristics for a diagnosis of HPV16-positive and HPV16-negative head and neck cancer. Oral Oncol. 2010;46:100-104.
33. Shi W, Kato H, Perez-Ordonez B, Pintilie M, Huang S, Hui A, et al. Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol. 2009;27:6213-6221.
34. Chung CH, Gillison ML. Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res. 2009;15:6758-6762.
35. Adelstein DJ, Ridge JA, Gillison ML, Chaturvedi AK, D'Souza G, Gravitt PE, et al. Head and neck squamous cell cancer and the human papillomavirus: summary of a National Cancer Institute State of the Science Meeting, November 9-10, 2008, Washington, D.C. Head Neck. 2009;31:1393-422.
36. Gillison ML. HPV and prognosis for patients with oropharynx cancer. Eur J Cancer. 2009;45 Suppl 1:383-385.
37. Gillison ML, D'Souza G, Westra W, Sugar E, Xiao W, Begum S, et al. Distinct risk factor profles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst. 2008;100:407-420.
38. Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, et al. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst. 2008;100:261-269.
39. Eglin RP, Scully C, Lehner T, Ward-Booth P, McGregor IA. Detection of RNA complementary to herpes simplex virus in human oral squamous cell carcinoma. Lancet. 1983;2:766-768.
40. Zheng Y, Xia P, Zheng HC, Takahashi H, Masuda S, Takano Y. The screening of viral risk factors in tongue and pharyngolaryngeal squamous carcinoma. Anticancer Res. 2010;30:1233-1238.
41. Bagan JV, Jiménez Y, Murillo J, Poveda R, Díaz JM, Gavaldá C, et al. Epstein-Barr virus in oral proliferative verrucous leukoplakia and squamous cell carcinoma: A preliminary study. Med Oral Patol Oral Cir Bucal. 2008;13:E110-E113.
42. Jalouli J, Ibrahim SO, Mehrotra R, Jalouli MM, Sapkota D, Lars-son PA, et al. Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fbrosis and oral cancer from India. Acta Otolaryngol. 2010;130:1306-1311.
43. Laborde RR, Novakova V, Olsen KD, Kasperbauer JL, Moore EJ, Smith DI. Expression profles of viral responsive genes in oral and oropharyngeal cancers. Eur J Cancer. 2010;46:1153-1158.
44. Yen CY, Lu MC, Tzeng CC, Huang JY, Chang HW, Chen RS, et al. Detection of EBV infection and gene expression in oral cancer from patients in Taiwan by microarray analysis. J Biomed Biotech-nol. 2009;2009:904589.
45. Kis A, Fehér E, Gáll T, Tar I, Boda R, Tóth ED, et al. Epstein-Barr virus prevalence in oral squamous cell cancer and in potentially malignant oral disorders in an eastern Hungarian population. Eur J Oral Sci. 2009;117:536-540.
46. Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, Schatzkin A, et al. Fruit and vegetable intake and head and neck cancer risk in a large United States prospective cohort study. Int J Cancer. 2008;122:2330-2336.
47. Bosetti C, Gallus S, Trichopoulou A, Talamini R, Franceschi S, Negri E, et al. Infuence of the Mediterranean diet on the risk of cancers of the upper aerodigestive tract. Cancer Epidemiol Biomarkers Prev. 2003;12:1091-1094.
48. Warnakulasuriya S. Food, nutrition and oral cancer. In: Food Constituents and Oral Health; Current Status and Future Prospects. Ed. Wilson M. Woodhead Publishing 2009. p. 273-295.
49. O'Shaughnessy JA, Kelloff GJ, Gordon GB, Dannenberg AJ, Hong WK, Fabian CJ, et al. Treatment and prevention of intraepithe-lial neoplasia: an important target for accelerated new agent development. Clin Cancer Res. 2002;8:314-346.
50. Nagao T, Ikeda N, Warnakulasuriya S, Fukano H, Yuasa H, Yano M, et al. Serum antioxidant micronutrients and the risk of oral leuko-plakia among Japanese. Oral Oncol. 2000;36:466-470.
51. Conway DI, Petticrew M, Marlborough H, Berthiller J, Hashibe M, Macpherson LM. Socioeconomic inequalities and oral cancer risk: a systematic review and meta-analysis of case-control studies. Int J Cancer. 2008;122:2811-2819.
52. Llewellyn CD, Linklater K, Bell J, Johnson NW, Warnakulas-uriya S. An analysis of risk factors for oral cancer in young people: a case-control study. Oral Oncol. 2004;40:304-313.
53. Llewellyn CD, Johnson NW, Warnakulasuriya KA. Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med. 2004;33:525-532.
54. Van Zeeburg HJ, Snijders PJ, Wu T, Gluckman E, Soulier J, Sur-ralles J, et al. Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients. J Natl Cancer Inst. 2008;100:1649-1653.
55. Fischer DJ, Epstein JB, Morton TH Jr, Schwartz SM. Reliability of histologic diagnosis of clinically normal intraoral tissue adjacent to clinically suspicious lesions in former upper aerodigestive tract cancer patients. Oral Oncol. 2005;41:489-496.
56. Brennan JA, Mao L, Hruban RH, Boyle JO, Eby YJ, Koch WM, et al. Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. N Engl J Med. 1995;332:429-435.
57. Bilde A, von Buchwald C, Dabelsteen E, Therkildsen MH, Da-belsteen S. Molecular markers in the surgical margin of oral carcinomas. J Oral Pathol Med. 2009;38:72-78.
58. Cortesina G, Martone T, Galeazzi E, Olivero M, De Stefani A, Bussi M, et al. Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases. Int J Cancer. 2000;89:286-292.
59. Santhi WS, Sebastian P, Varghese BT, Prakash O, Pillai MR. NF-kappaB and COX-2 during oral tumorigenesis and in assessment of minimal residual disease in surgical margins. Exp Mol Pathol. 2006;81:123-130.
60. Shaw RJ, Hall GL, Woolgar JA, Lowe D, Rogers SN, Field JK, et al. Quantitative methylation analysis of resection margins and lymph nodes in oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 2007;45:617-622.
61. Shaw RJ, Liloglou T, Rogers SN, Brown JS, Vaughan ED, Lowe D, et al. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyro-sequencing. Br J Cancer. 2006;94:561-568.
62. Ball VA, Righi PD, Tejada E, Radpour S, Pavelic ZP, Gluck-man JL. p53 immunostaining of surgical margins as a predictor of local recurrence in squamous cell carcinoma of the oral cavity and oropharynx. Ear Nose Throat J. 1997;76:818-823.
63. Tjebbes GW, Leppers vd Straat FG, Tilanus MG, Hordijk GJ, Slootweg PJ. p53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: p53 mutations in primary tumor and matched lymph node metastases. Oral Oncol. 1999;35:384-389.
64. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000;6:1702-1710.
65. Scully C, Sudbø J, Speight PM. Progress in determining the malignant potential of oral lesions. J Oral Pathol Med. 2003;32:251-256.
66. Marron M, Boffetta P, Zhang ZF, Zaridze D, Wünsch-Filho V, Winn DM, et al. Cessation of alcohol drinking, tobacco smok ing and the reversal of head and neck cancer risk. Int J Epidemiol. 2010;39:182-196.
67. Poate TW, Warnakulasuriya S. Effective management of smoking in an oral dysplasia clinic in London. Oral Dis. 2006;12:22-26.
68. Gillison ML. Human papillomavirus-related diseases: orophar-ynx cancers and potential implications for adolescent HPV vaccination. J Adolesc Health. 2008;43:S52-S60.